Persyst 14 EEG Review and Analysis Software is an AI-enabled medical device from Persyst Development Corporation, listed by FDA (510(k), K182181) with a decision date of 2018-11-29. Review panel: Neurology.
| FDA submission number | K182181 |
|---|---|
| Pathway | 510(k) |
| Company | Persyst Development Corporation |
| Review panel (specialty) | Neurology |
| FDA decision date | 2018-11-29 |
| Decision | Substantially Equivalent |
| Product code | OMB |
| Classification | Automatic Event Detection Software For Full-Montage Electroencephalograph |
| Device class | 2 |
| Regulation number | 882.1400 |
| Review time (calendar days) | 108 |
| Applicant country | US |
Official FDA database record · FDA AI-enabled device list
All Neurology AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.